140 related articles for article (PubMed ID: 9680929)
1. Persistent B19 parvovirus infection in pediatric malignancies.
Broliden K; Tolfvenstam T; Ohlsson S; Henter JI
Med Pediatr Oncol; 1998 Aug; 31(2):66-72. PubMed ID: 9680929
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
3. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
4. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders.
Lundqvist A; Tolfvenstam T; Brytting M; Stolt CM; Hedman K; Broliden K
Scand J Infect Dis; 1999; 31(2):119-22. PubMed ID: 10447317
[TBL] [Abstract][Full Text] [Related]
6. Serologic study on parvovirus b19 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications.
Heegaard ED; Schmiegelow K
J Pediatr Hematol Oncol; 2002; 24(5):368-73. PubMed ID: 12142785
[TBL] [Abstract][Full Text] [Related]
7. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow.
Lundqvist A; Tolfvenstam T; Bostic J; Söderlund M; Broliden K
Scand J Infect Dis; 1999; 31(1):11-6. PubMed ID: 10381211
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy.
El-Mahallawy HA; Mansour T; El-Din SE; Hafez M; Abd-el-Latif S
J Pediatr Hematol Oncol; 2004 Jul; 26(7):403-6. PubMed ID: 15218412
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of parvovirus B 19 infection in children with aplastic anemia.
Gupta V; Saini I; Nath G
Indian Pediatr; 2013 May; 50(5):489-91. PubMed ID: 23255678
[TBL] [Abstract][Full Text] [Related]
13. Molecular Study of Parvovirus B19 Infection in Children with Acute Myeloid Leukemia.
Tharwat Abou El-Khier N; Darwish A; El Sayed Zaki M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):337-342. PubMed ID: 29479965
[TBL] [Abstract][Full Text] [Related]
14. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals.
Heegaard ED; Petersen BL; Heilmann CJ; Hornsleth A
J Clin Microbiol; 2002 Mar; 40(3):933-6. PubMed ID: 11880419
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity virus and mycoplasma screening test reveals high prevalence of parvovirus B19 infection in human synovial tissues and bone marrow.
Watanabe K; Otabe K; Shimizu N; Komori K; Mizuno M; Katano H; Koga H; Sekiya I
Stem Cell Res Ther; 2018 Mar; 9(1):80. PubMed ID: 29587847
[TBL] [Abstract][Full Text] [Related]
17. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
Ferri C; Zakrzewska K; Longombardo G; Giuggioli D; Storino FA; Pasero G; Azzi A
Clin Exp Rheumatol; 1999; 17(6):718-20. PubMed ID: 10609071
[TBL] [Abstract][Full Text] [Related]
19. A pilot study on parvovirus B19 infection in paediatric haematological malignancies.
Kishore J; Sen M; Kumar A; Kumar A
Indian J Med Res; 2011 Apr; 133(4):407-13. PubMed ID: 21537094
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19-associated disease in bone marrow transplantation.
Schleuning M; Jäger G; Holler E; Hill W; Thomssen C; Denzlinger C; Lorenz T; Ledderose G; Wilmanns W; Kolb HJ
Infection; 1999; 27(2):114-7. PubMed ID: 10219641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
